Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)

TPE:1720 Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	7,035	7,023	6,789	6,240	5,851	4,604
Revenue Growth	3.21%	3.44%	8.81%	6.64%	27.09%	6.94%
Gross Profit Gross Profit Growth	2,929	2,909	2,989	2,725	2,488	2,068
Operating Income Operating Income Growth	1,389	1,363	1,397	1,260	1,118	876.83
Net Income Net Income Growth	964.51	927.66	880.5	834.89	815.41	706.73
Earnings Per Share EPS Growth	4.89	4.71	4.47	4.25	4.15	3.59
EPS Growth	16.96%	5.29%	5.35%	2.41%	15.45%	34.81%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Internal Divisions Internal Divisions Growth	-291.17	-293.95	-273.44	-266.89	-270.7	-176.49
Human medicine Human medicine Growth	3,416	3,314	3,189	2,951	2,602	2,589
Food Food Growth	2,253	2,307	2,182	2,026	2,057	1,664
Active Pharmaceutical Ingredient Active Pharmaceutical Ingredient Growth	1,331	1,376	1,378	1,180	1,072	-
Others Others Growth	326.62	319.65	314.2	349.74	391.23	527.56
Total Total Growth	7,035	7,023	6,789	6,240	5,851	4,604

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	2,383	2,385	1,804	2,268	2,480	2,757
Total Debt Total Debt Growth	916.33	948.82	560.43	1,328	1,790	1,668
Net Cash (Debt) Net Cash Growth	1,467	1,436	1,244	939.65	689.98	1,089
Net Cash Growth	10.89%	15.49%	32.34%	36.19%	-36.65%	56.47%
Net Cash Per Share Net Cash Per Share Growth	7.45	7.30	6.32	4.78	3.51	5.53

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	1,866	1,767	1,695	1,337	1,228	827.03
Capital Expenditures CapEx Growth	-453.92	-492.87	-596.48	-625.7	-1,196	-213.48
Free Cash Flow Free Cash Flow Growth	1,412	1,274	1,098	710.83	31.78	613.56
Free Cash Flow Growth	22.54%	15.98%	54.53%	2136.85%	-94.82%	7.63%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	41.64%	41.42%	44.02%	43.68%	42.51%	44.91%
Operating Margin	19.75%	19.41%	20.57%	20.19%	19.11%	19.05%
Pretax Margin	21.89%	21.56%	23.97%	23.04%	23.92%	22.02%
Profit Margin	13.71%	13.21%	12.97%	13.38%	13.94%	15.35%
FCF Margin	20.08%	18.14%	16.18%	11.39%	0.54%	13.33%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	1.818	1.818	2.546	2.454	2.273	2.273
Dividend Per Share Growth	-21.43%	-28.57%	3.71%	8.00%	0%	38.88%
Dividend Yield	3.24%	3.51%	4.91%	4.61%	4.76%	7.18%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	11.65	11.35	12.56	14.11	13.48	10.90
Forward PE	-	11.46	12.75	11.83	11.83	14.74
P/FCF Ratio	7.93	8.26	10.07	16.57	345.83	12.55
PS Ratio	1.59	1.50	1.63	1.89	1.88	1.67

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 7, 2026

Data Sources Report a data error